15 Amendments of Anna ROSBACH related to 2013/2022(INI)
Amendment 9 #
Motion for a resolution
Citation 6 a (new)
Citation 6 a (new)
- having regard to the report of the Committee on the Environment, Public Health and Food Safety on the Microbial Challenge - Rising threats from Antimicrobial Resistance (2012/2041(INI)),
Amendment 15 #
Motion for a resolution
Citation 6 b (new)
Citation 6 b (new)
- having regard to the Commission communication of 15 November 2011 on an action plan against the rising threats from antimicrobial resistance (COM(2011)0748),
Amendment 16 #
Motion for a resolution
Citation 6 c (new)
Citation 6 c (new)
- having regard to the Council conclusions of 22 June 2012 on 'The impact of antimicrobial resistance in the human health sector and in the veterinary sector – a "One Health" perspective',
Amendment 32 #
Motion for a resolution
Recital A
Recital A
A. whereas patient safety isand wellbeing are key to overall healthcare quality;
Amendment 57 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas it is estimated that the annual number of patients with acquiring at least one Healthcare Associated Infection during their stays in European acute care hospitals in 2011-2012, in the European Union as a whole is 3.2 million 1 . __________________ 1 according to Commission reply E- 004648/2013
Amendment 77 #
Motion for a resolution
Recital K a (new)
Recital K a (new)
Ka. whereas only 13 Member States have implemented national surveillance of Clostridium difficile infections1 and in only 3 of the surveillance systems are general practitioners also involved in the data collection - a situation that should be improved. E-004649/2013 __________________ 1 According to reply from the Commission E-004649/2013 these 13 countries are: Austria, Belgium, Bulgaria, Denmark, Germany, Finland, France, Hungary, Ireland, the Netherlands, Spain, Sweden and United Kingdom. http://www.europarl.europa.eu/sides/getAl lAnswers.do?reference=E-2013- 004649&language=EN
Amendment 81 #
Motion for a resolution
Recital D a (new)
Recital D a (new)
Da. whereas there is a decline in the development of new antimicrobials
Amendment 83 #
Motion for a resolution
Recital F a (new)
Recital F a (new)
Fa. whereas the issue of antimicrobial resistance is a serious, and in some countries growing, threat to patient safety, that can complicate the recovery from and treatment of infections and that increases the national costs for health;
Amendment 103 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Welcomes the measures put in place by Member States with the principal aim of improving general patient safety and reducing the incidence of HAIs, but urges that these efforts must be increased;
Amendment 106 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Welcomes the steps taken by the Commission to improve general patient safety by promoting mutual learningexchange of best practice between Member States and putting forward common definitions and terminology for patient safety;
Amendment 111 #
Motion for a resolution
Paragraph 4 – indent 2 a (new)
Paragraph 4 – indent 2 a (new)
- have action plans in place for combating HAIs
Amendment 117 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Urges the Member States to continue their efforts to improve patient safety by taking, if they have not already done so, new measures, including setting up action plans for combating HAIs, in order to fall fully into line with the Council's recommendations;
Amendment 127 #
Motion for a resolution
Paragraph 10 – indent 4 a (new)
Paragraph 10 – indent 4 a (new)
- measures to prevent the occurrence as well as combat the spread of antimicrobial resistance including the development of new antimicrobials;
Amendment 227 #
Motion for a resolution
Paragraph 34
Paragraph 34
34. Encourages the ECDC in its efforts to support and standardise the monitoring of HAIs, and, in particular, calls on it to continue developing structure and process indicators and to facilitate the exchange of best practice in monitoring HAIs;
Amendment 232 #
Motion for a resolution
Paragraph 35
Paragraph 35
35. Calls on the Member States to establish a joint database to be used to compile information concerning adverse events in healthcare and to encourage the use of all relevant data collection mechanisms (including those based on confidential declarations) and for this database to be shared with both the Commission and the ECDC;